An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21-1) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions
- 1 December 1999
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 26 (3) , 149-155
- https://doi.org/10.1016/s0169-5002(99)00084-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Clinical value of CYFRA 21.1, carcinoembryonic antigen, neurone-specific enolase, tissue polypeptide specific antigen and tissue polypeptide antigen in the diagnosis of lung cancerEuropean Respiratory Journal, 1997
- Clinical applications of serum markers for lung cancerRespiratory Medicine, 1995
- Clinical usefulness of serum assays of neuron-specific enolase, carcinoembryonic antigen and CA-50 antigen in the diagnosis of lung cancerEuropean Journal Of Cancer, 1993
- Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part I. Theory.Radiology, 1993
- Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.Radiology, 1992
- Clinical Applications of Serum Tumor MarkersAnnals of Internal Medicine, 1991
- Clinical value of a multiple biomarker assay in patients with bronchogenic carcinomaCancer, 1986
- Serum Neuron-Specific EnolaseChest, 1985
- Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study GroupCancer, 1984
- THE SOLITARY PULMONARY NODULEJournal of Thoracic Surgery, 1956